Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 May 16;26(Suppl 2):ii252-ii263.
doi: 10.1093/eurheartjsupp/suae030. eCollection 2024 Apr.

Cardio-oncology rehabilitation: are we ready?

Affiliations

Cardio-oncology rehabilitation: are we ready?

Irma Bisceglia et al. Eur Heart J Suppl. .

Abstract

Cardio-oncology rehabilitation (CORE) is not only an essential component of cancer rehabilitation but also a pillar of preventive cardio-oncology. Cardio-oncology rehabilitation is a comprehensive model based on a multitargeted approach and its efficacy has been widely documented; when compared with an 'exercise only' programme, comprehensive CORE demonstrates a better outcome. It involves nutritional counselling, psychological support, and cardiovascular (CV) risk assessment, and it is directed to a very demanding population with a heavy burden of CV diseases driven by physical inactivity, cancer therapy-induced metabolic derangements, and cancer therapy-related CV toxicities. Despite its usefulness, CORE is still underused in cancer patients and we are still at the dawning of remote models of rehabilitation (tele-rehabilitation). Not all CORE is created equally: a careful screening procedure to identify patients who will benefit the most from CORE and a multidisciplinary customized approach are mandatory to achieve a better outcome for cancer survivors throughout their cancer journey. The aim of this paper is to provide an updated review of CORE not only for cardiologists dealing with this peculiar population of patients but also for oncologists, primary care providers, patients, and caregivers. This multidisciplinary team should help cancer patients to maintain a healthy and active life before, during, and after cancer treatment, in order to improve quality of life and to fight health inequities.

Keywords: Cardiac rehabilitation; Cardio-oncology rehabilitation (CORE); Core components of CORE; Geriatric oncologic patients; Reverse cardio-oncology; Telehealth in rehabilitation.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest: none declared.

Figures

Figure 1
Figure 1
Cardio-oncology rehabilitation operating flow chart.

Similar articles

References

    1. Wang Z, Fan Z, Yang L, Liu L, Sheng C, Song Fet al. . Higher risk of cardiovascular mortality than cancer mortality among long-term cancer survivors. Front Cardiovasc Med 2023;10:1014400. PMID: 36760569; PMCID: PMC9905625. - PMC - PubMed
    1. Zullig LL, Sung AD, Khouri MG, Jazowski S, Shah NP, Sitlinger Aet al. . Cardiometabolic comorbidities in cancer survivors: JACC: CardioOncology state-of-the-art review. JACC CardioOncol 2022;4:149–165. PMID: 35818559; PMCID: PMC9270612. - PMC - PubMed
    1. Gilchrist SC, Barac A, Ades PA, Alfano CM, Franklin BA, Jones LWet al. . Cardio-oncology rehabilitation to manage cardiovascular outcomes in cancer patients and survivors: a scientific statement from the American Heart Association. Circulation 2019;139:e997–e1012. PMID: 30955352; PMCID: PMC7603804. - PMC - PubMed
    1. Rickard JN, Eswaran A, Small SD, Bonsignore A, Pakosh M, Oh Pet al. . Evaluation of the structure and health impacts of exercise-based cardiac and pulmonary rehabilitation and prehabilitation for individuals with cancer: a systematic review and meta-analysis. Front Cardiovasc Med 2021;8:739473. - PMC - PubMed
    1. Bisceglia I, Canale ML, Silvestris N, Gallucci G, Camerini A, Inno Aet al. . Cancer survivorship at heart: a multidisciplinary cardio-oncology roadmap for healthcare professionals. Front Cardiovasc Med 2023;10:1223660. Erratum in: Front Cardiovasc Med 2023;10:1309921. PMID: 37786510; PMCID: PMC10541962. - PMC - PubMed